Latest Search
Quote
| Back Zoom + Zoom - | ||||
|
<Research>G Sachs Keeps Neutral on WUXI BIO (02269.HK) with TP HKD25.6
Recommend 4 Positive 12 Negative 14 |
||||
|
||||
|
Goldman Sachs published a research report on WUXI BIO (02269.HK), which issued a positive profit alert, expecting interim revenue to grow approximately 16% YoY, aligning with the full-year growth guidance of 12-15%. Net profit was expected to hike by 56% YoY, slightly topping forecast. Goldman Sachs maintained a Neutral rating on WUXI BIO and a target price of HKD25.6, expecting investors to focus on the growth momentum of new orders outside of ADC/XDC, progress of late-stage and commercialization projects, and the expansion pace of overseas capacity. AASTOCKS Financial News Website: www.aastocks.com |
||||
Copied to Clipboard
 |
||||
